Zivo Bioscience Inc - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS

Ticker Exchange SIC # Website Latest Ticker
ZIVO Nasdaq 2833 https://zivobioscience.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Zivo Bioscience Inc

Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq - Apr 25th, 2022 8:05 pm
ZIVO Bioscience Names Chairman John B. Payne as President and CEO - Jan 10th, 2022 10:00 pm
Zivo Bioscience, Inc. to Participate in the Global AgTech Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on October 14, 2021 at 10 A.M. EDT - Oct 6th, 2021 2:10 pm
Weblink Instructions for the Annual Meeting of Shareholders of Zivo Bioscience, Inc. - Oct 5th, 2021 4:57 pm
Amazon Event 2021: 5 New Product Predictions That Could Be Coming Sept. 28 - Sep 24th, 2021 3:35 pm
ZIVO Stock: 6 Things to Know About Biotech ZIVO Bioscience as Shares Rocket on No News - Sep 24th, 2021 3:04 pm
Zivo Bioscience, Inc. Issues Letter to Shareholders - Aug 17th, 2021 8:05 pm
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021 - Aug 16th, 2021 12:30 pm
Zivo Bioscience to Present at Two Upcoming August Conferences - Aug 11th, 2021 12:00 pm
ZIVO Bioscience to Present at the Q3 Virtual Investor Summit - Aug 11th, 2021 11:00 am
Zivo Bioscience, Inc. Announces Closing of Underwriters’ Partial Exercise of Over-Allotment Option in Connection with its Previously Announced Public Offering - Jul 2nd, 2021 12:00 pm
ZIVO Bioscience to Present at the LD Micro Virtual Invitational Conference on June 9, 2021 - Jun 2nd, 2021 1:30 pm
Zivo Bioscience, Inc. Announces Closing of Upsized $13.8 Million Public Offering and Uplisting to Nasdaq - Jun 2nd, 2021 1:05 pm
Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq - May 28th, 2021 12:42 am